Although APOE-e4 is the strongest common risk variant for late-onset of AD, its prediction accuracy is limited [8], and other variants discovered though genome-wide association studies (GWAS) have small individual effects [9, 10]. The gene discussed is APOE; the disease is Alzheimer disease.